PMC7883396_01
Case Report Timeline: Patient was initially diagnosed in July 2014, and received EBRT, a radical thyroidectomy, and radioiodine therapy. Metastatic bone tumors were found in January 2017 and the patient received additional EBRT. Seven months later the patient reported decreased quality of life and new symptoms and began systemic treatment with lenvatinib. Adverse events and dose modifications were managed cooperatively between the local treatment team and the specialist oncologist. As of April 2020, the patient remained stable, with an ECOG PS of 1. CT, computed tomography; EBRT, external beam radiotherapy; ECOG PS, Eastern Cooperative Oncology Group performance status; QoL, quality of life.
fendo-11-581014-g001.jpg
PMC7883396_01_fendo-11-581014-g001.jpg
f1
At a follow-up appointment following an elective knee-joint replacement in 2014, the patient presented with both urinary and occasional fecal incontinence with associated back pain ( Figure 1 ).
Sacral Mass at Diagnosis (July 2014).
fendo-11-581014-g002.jpg
PMC7883396_01_fendo-11-581014-g002.jpg
f2
The patient was admitted to a regional hospital in Inverness, more than 100 miles away, for an X-ray and magnetic resonance imaging scan of the spine, which showed a sacral mass of 9.0 cm x 4.7 cm x 4.0 cm encroaching on the S1-5 foramina as the likely cause of symptoms ( Figure 2 ).